Cefoperazone Sodium I.P (Sterile)
Cefotaxime Sodium I.P (Sterile)
Cefuroxime Sodium I.P (Sterile)
Ceftazidime I.P (Sterile)
Cefepime HCL I.P (Sterile)
Cefepime HCL and L-arginine I.P (Sterile)
Meropenam IP/ USP (Sterile)
Imipenem I.P (Sterile)
Aztreonam USP (Sterile) Dry Mixture of Aztreonam & Arginine)
Aztreonam USP (Sterile) (L-Arginine Content 41%-45%)
Teicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spectrum of activity similar to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis.
Amoxicillin Sodium and Clauvulanate Potassium is an antibiotic useful for the treatment of a number of bacterial infections. It is a combination antibiotic consisting of amoxicillin sodium, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor
Tazobactam is a pharmaceutical drug that inhibits the action of bacterial β-lactamases, especially those belonging to the SHV-1 and TEM groups. Tazobactam is combined with the extended spectrum β-lactam antibiotic piperacillin in the drug piperacillin/tazobactam, one of the preferred antibiotic treatments for nosocomial pneumonia caused by Pseudomonas aeruginosa
Ticarcillin is a carboxypenicillin and invariably sold in combination with potassium clavulanate. Its main clinical use is as an injectable antibiotic for the treatment of Gram-negative bacteria, particularly Pseudomonas aeruginosa. It is also one of the few antibiotics capable of treating Stenotrophomonas maltophilia infections.
Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.
Vancomycin HCL is an antibiotic useful for the treatment of a number of bacterial infections. It is of the glycopeptide antibiotic class and is effective mostly against Gram-positive bacteria.
Broad-spectrum cephalosporin resistant to beta-lactamase. Inhibitor of inactivation of α 1-antitrypsin. Shows antibacterial effect. It is one of few cephalosporin antibiotics effective in treating Pseudomonas bacterial infections which are otherwise resistant to these antibiotics.
Cefotaxime Sodium I.P (Sterile) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, cefotaxime is a broad-spectrum antibiotic with activity against numerous Gram-positive and Gram-negative bacteria. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
Cefuroxime is a parenteral or oral second-generation cephalosporin antibiotic. Although as a second-generation variety, it is less susceptible to beta-lactamase. Hence, it may have greater activity againstHaemophilus influenzae, Neisseria gonorrhoeae, and Lyme disease. Unlike most other second-generation cephalosporins, cefuroxime can cross the blood-brain barrier.
Ceftazidime is an antibiotic useful for the treatment of a number of bacterial infections. It is a third-generation cephalosporin. Ceftazidime is one of the few in this class with activity against Pseudomonas.
Cefepime HCL is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime is usually reserved to treat moderate to severe nosocomial pneumonia, infections caused by multiple drug-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia. Cefepime has good activity against important pathogens including Pseudomonas aeruginosa, Staphylococcus aureus, and multiple drug-resistant Streptococcus pneumoniae. A particular strength is its activity against Enterobacteriaceae.
Combination is available as bulk sterile powder for injections. Cefepime HCL is a fourth-generation cephalosporin antibiotic. L-arginine, at an approximate concentration of cefepime, is added to control the pH of the constituted solution at 4 to 6 during treatment.
Meropenem is an ultra-broad-spectrum injectable antibiotic used to treat a wide variety of infections. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. The spectrum of action includes many Gram-positive and Gram-negative bacteria (including Pseudomonas) and anaerobic bacteria. The overall spectrum is similar to that of imipenem, although meropenem is more active against Enterobacteriaceae and less active against Gram-positive bacteria.
Meropenem is frequently given in the treatment of febrile neutropenia. This condition frequently occurs in patients with hematological malignancies and cancer patients receiving anticancer drugs that cause bone marrow suppression. It is approved for complicated skin and skin structure infections, complicated intra-abdominal infections and bacterial meningitis.
Imipenem (Primaxin) is an intravenous β-lactam antibiotic and first member of the carbapenem class of antibiotics. Imipenem has a broad spectrum of activity against aerobic and anaerobic, Gram-positive and Gram-negative bacteria.Important for its activity against Pseudomonas aeruginosa and the Enterococcus species.
An combination antibiotic useful for the treatment of a number of bacterial infections. It is a broad-spectrum beta-lactam containing equal quantities of imipenem and cilastatin. Indications: lower respiratory tract infections , urinary tract infections , intra-abdominal infections , gynecologic infections, bacterial septicemia ,bone and joint infections , skin and skin structure infections ,endocarditis and polymicrobic infections.
Synthetic monocyclic beta-lactam antibiotic (a monobactam) Aztreonam has strong activity against susceptible Gram-negative bacteria, including Pseudomonas aeruginosa. It is known to be effective against a wide range of bacteria including Citrobacter, Enterobacter, E. coli, Haemophilus, Klebsiella, Proteus, and Serratia species. Synergism between aztreonam and arbekacin or tobramycin against P. aeruginosa has been suggested.
Synthetic monocyclic beta-lactam antibiotic (a monobactam) Aztreonam has strong activity against susceptible Gram-negative bacteria, including Pseudomonas aeruginosa. It is known to be effective against a wide range of bacteria including Citrobacter, Enterobacter, E. coli, Haemophilus, Klebsiella, Proteus, and Serratia species.
Upper and lower respiratory tract infections
Urinary tract infections
Skin and soft tissue infections
upper and lower respiratory tract infections
urinary tract infections
skin and soft tissue infections